IGF::OT::IGF Aerosolized Delivery of Anti-Tubercular Drugs

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$210,507.00
Award Year:
2013
Program:
SBIR
Phase:
Phase I
Contract:
N43AI130014
Agency Tracking Number:
N43AI130014
Solicitation Year:
2013
Solicitation Topic Code:
NIAID
Solicitation Number:
n/a
Small Business Information
PROTEIN ADVANCES, INC.
PROTEIN ADVANCES, INC., 1102 Columbia Street Ste 110, SEATTLE, WA, 98104-2025
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
148051621
Principal Investigator:
DARRICK CARTER
(206) 623-0331
DARRICK.CARTER@PROTEINAI.COM
Business Contact:
DARRICK CARTER
(206) 623-0331
DARRICK.CARTER@PROTEINAI.COM
Research Institution:
Stub




Abstract
Develop an inexpensive, easy to use, aerosolized delivery system of a combination of anti-tubercular drugs that could be used for the treatment of multi-drug resistant tuberculosis (MDR TB ). PUBLIC HEALTH RELEVANCE

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government